Capital Signal

Star Combo Pharma Limited (ASX: S66)

Sector: Consumer Staples

Market cap: A$19M (as of 2 Nov 2026)

Manufacturing dietary supplement products

Data as of 2 Nov 2026.

Recent capital raises

DateTypeAmountPriceDiscountSource
26 May 2020Placement$33.3M$0.68—Filing ↗
9 Aug 2019Placement$50M——Filing ↗
7 July 2019SPP$1M$0.5619.32% discountFiling ↗

Substantial holders — latest moves

DateHolderMoveHoldingSource
24 Oct 2025Goldenstar Pharmaceutical Investment LimitedEntry?% → 36.27%Filing ↗
25 Oct 2024Goldenstar Pharmaceutical Investment LimitedEntry?% → 36.27%Filing ↗
12 June 2020SARGON CT PTY LTDExit—Filing ↗
3 June 2020LEPU MEDICAL (EUROPE) COOPERATIEF U.A.Decrease13.83% → 8.11%Filing ↗
2 June 2020Jinxing (Star) ZhangDecrease47.97% → 28.14%Filing ↗

Ask about S66 in Claude or ChatGPT

Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:

  • Has S66 raised money in the last year, and at what discount?
  • What was S66's latest cash position and runway?

Setup guide for Claude, ChatGPT and other MCP clients →

Loading S66…

Star Combo Pharma Limited (ASX: S66): capital raises, holders, director trades | Capital Signal